NCT05597761View on ClinicalTrials.gov

Immunogenicity of COVID-19 Vaccination in Immunocompromised Patients (Auto-COVID-VACC)

Active, not recruitingOBSERVATIONAL
Enrollment

49

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
COVID-19AdultImmunocompromised Patients
Trial Locations (3)

45147

Universitätsklinikum Essen Klinik für Hämatologie und Stammzellentransplantation, Essen

50937

University Hospital of Cologne, Cologne

52074

Klinik für Hämatologie, Onkologie, Hämostaseologie und Stammzelltransplantation (Med. Klinik IV) Uniklinik der RWTH Aachen, Aachen

All Listed Sponsors
collaborator

ZKS Köln

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

Oliver Cornely, MD

OTHER